All times are ET. PRIVATE. Metabolon Receives Growth Capital from Pre-IPO Investor GREENWOOD VILLAGE, Colo., Aug 30, 2011 (BUSINESS WIRE) -- Keating Capital, Inc. ( www.KeatingCapital.com ), a pre-IPO investment fund, Metabolon, Inc. is the world’s leading health technology company advancing metabolomics for precision medicine and all areas of life sciences research. Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. GUT, the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market. FiRe 2016 will take place September 27-30, 2016, at the Stein Eriksen Lodge Deer Valley in Park City, Utah. Cancel. More. GUT collection device," said Scott Rabuka, Senior Director, Molecular Products at DNA Genotek, Inc. SEATTLE, WA--(Marketwired - September 01, 2016) - Strategic News Service (SNS) has selected Metabolon Inc., the global leader in metabolomics, as a 2016 FiReStarter company to be featured at the 14th Annual Future in Review (FiRe) conference. It offers biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Summary Metrics. Metabolon Debuts New Client Portal at Bio-IT World Expo MetaboLync™:A Cloud-based Solution for Sharing, Visualizing, and Analyzing Metabolomics Data RESEARCH TRIANGLE PARK, N.C., Apr 29, 2014 (BUSINESS WIRE) — Metabolon, Inc., a leader in metabolomics-driven biomarker discovery, announced today the debut and impending launch of MetaboLync, the company’s innovative product offering … The company provides biochemical markers and information for understanding biochemical … Real-time trade and investing ideas on Metabolon, Inc. BOLON from the largest community of traders and investors. View Company. Cancer … Company News. Metabolon Funding. S&P 500 0.00%. Up-to-the-minute news and analysis on deals, markets and finance around the world. Metabolon stock price, funding rounds, valuation and financials. Metabolon, Inc. Watch . Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that it has filed a patent infringement lawsuit against Stemina Biomarker Discovery, Inc. in the US District Court for the Western District of Wisconsin. Rohan F Hastie is President/CEO at Metabolon Inc. See Rohan F Hastie's compensation, career history, education, & memberships. Most stock quote data provided by BATS. Sign Up. Strategic News Service has selected Metabolon Inc., the global leader in metabolomics, as a 2016 FiReStarter company to be featured at the 14th Annual Future in Review conference. Eric A Button is Senior VP:Diagnostics at Metabolon Inc. See Eric A Button's compensation, career history, education, & memberships. DOW 0.00%. Stock Summary; Articles; BioCentury | Oct 11, 2019. Rooms Trade App. This round of financing included Perceptive Advisors as a … Jonathan Block, Associate Editor U.S. Food and Drug Administration (FDA) Galera Therapeutics Inc. Aridis Pharmaceuticals Inc. Palladio Biosciences Inc. Metabolon Inc.... Read More. (PRWEB) September 01, 2011 -- Keating Capital, Inc., a pre-IPO investment fund, announced that on August 25, 2011, it made a $4 million investment in the $13 GUT collection device," said Scott Rabuka , Senior Director, Molecular Products at DNA Genotek, Inc. 13.12 Metabolon, Inc. Other Related Market Research Reports: Biopreservation Market Size is Projected to be AroundUS$ 4.50 Billion By 2022. 2. Trevor Casserly Research Scientist, Research and Discovery at Metabolon, Inc. Raleigh-Durham-Chapel Hill Area 500+ connections Metabolon Inc., a medical technology firm that tests how diseases and drugs affect the body, is working on an IPO that could launch in the next couple months, people familiar with the … GUT, the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market. Metabolon - The latest news about Metabolon from the WSJ MoneyBeat Blog. Developer of analytical methods software designed to use metabolomics to develop precision medicine. Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. Its proprietary platforms and informatics systems are delivering biomarker discoveries, innovative diagnostic tests, breakthroughs in precision medicine, and robust partnerships in genomics-based health initiatives. Its Precision Metabolomics ™ is a powerful, patented technology for assessing health and delivering biomarker discoveries, innovative diagnostic tests, and valuable data for genomics and population health initiatives. Real-time trade and investing ideas on Metabolon, Inc. BOLON from the largest community of traders and investors. Metabolon, Inc. BOLON. Log In. Michael Rasche is Pres:International Business at Metabolon Inc. See Michael Rasche's compensation, career history, education, & memberships. NASDAQ 0.00%. Management tracks: Chan leaving FDA’s China office; plus Galera, Aridis and Palladio...CEO post. Disclaimer. Trending now. Metabolon, Inc. is the world’s leading life sciences company focused on metabolomics – an integrative, powerful technology for assessing health. Press Release Metabolomics Market Global Insights and Growing Trend Analysis 2020-2026: Thermo Fisher Scientific, Metabolon, Inc., Bruker Corporation Inc., Metabolon, Inc., a technology company, develops analytical methods and software for biomarker discovery using metabolomics. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Metabolon General Information Description. BioCentury | Sep 10, 2018. Metabolon has raised $95.40 m in total funding. Shareholders of Harris & Harris Group, Inc., may be interested to read Metabolon's press release, "Metabolon & Baylor College of Medicine Partner to Launch Global... | January 3, 2021